Table 3.
The relationship among MTA2, Ki-67 and pathological features
| Age | Pathological grade | Tumor size | T stage | LMN | Metastasis | TNM stage | Sex | ||
|---|---|---|---|---|---|---|---|---|---|
| Nuclear MTA2 (Cancer) | Correlation | .223 | .202 | .101 | .119 | -.083 | .242* | .110 | .049 |
| P value | .051 | .076 | .379 | .320 | .488 | .039 | .358 | .667 | |
| N | 77 | 78 | 78 | 72 | 72 | 73 | 72 | 78 | |
| Nuclear MTA2 (Paracancerous) | Correlation | . | . | . | . | . | . | . | . |
| P value | . | . | . | . | . | . | . | . | |
| N | 76 | 77 | 77 | 71 | 71 | 72 | 71 | 77 | |
| Cytoplasmic MTA2 (Cancer) | Correlation | -.126 | -.190 | .133 | -.006 | -.099 | . | -.006 | .078 |
| P value | .279 | .097 | .247 | .960 | .410 | . | .960 | .499 | |
| N | 76 | 77 | 77 | 71 | 71 | 72 | 71 | 77 | |
| Cytoplasmic MTA2 (Paracanerous) | Correlation | -.158 | -.133 | .161 | .108 | -.052 | . | .108 | -.099 |
| P value | .173 | .249 | .162 | .372 | .668 | . | .372 | .392 | |
| N | 76 | 77 | 77 | 71 | 71 | 72 | 71 | 77 | |
| Positive rate of Ki-67 | Correlation | .066 | .307** | .099 | .155 | -.108 | -.076 | .129 | .046 |
| P value | .554 | .004 | .372 | .170 | .340 | .504 | .255 | .678 | |
| N | 83 | 84 | 83 | 80 | 80 | 80 | 80 | 84 |